Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Pathologic changes after interstitial laser therapy of infiltrating breast carcinoma.

Bloom KJ, Dowlat K, Assad L.

Am J Surg. 2001 Oct;182(4):384-8.

PMID:
11720676
2.

Laser therapy for small breast cancers.

Dowlatshahi K, Francescatti DS, Bloom KJ.

Am J Surg. 2002 Oct;184(4):359-63.

PMID:
12383903
3.

Assessment of proliferating cell nuclear antigen activity using digital image analysis in breast carcinoma following magnetic resonance-guided interstitial laser photocoagulation.

Korourian S, Klimberg S, Henry-Tillman R, Lindquist D, Jones M, Eng DC, Helsel JC, Mumtaz H, Westbrook K, Harms S.

Breast J. 2003 Sep-Oct;9(5):409-13.

PMID:
12968963
4.
5.

Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision.

Burak WE Jr, Agnese DM, Povoski SP, Yanssens TL, Bloom KJ, Wakely PE, Spigos DG.

Cancer. 2003 Oct 1;98(7):1369-76.

7.

Interstitial laser thermotherapy (ILT) of breast cancer.

Haraldsdóttir KH, Ivarsson K, Götberg S, Ingvar C, Stenram U, Tranberg KG.

Eur J Surg Oncol. 2008 Jul;34(7):739-45. doi: 10.1016/j.ejso.2008.01.008. Epub 2008 Mar 4.

PMID:
18291614
8.

Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation.

Pusztaszeri M, Vlastos G, Kinkel K, Pelte MF.

Cryobiology. 2007 Aug;55(1):44-51. Epub 2007 Jun 2.

PMID:
17604016
9.

Pleomorphic ductal carcinoma of the breast with predominant micropapillary features.

Lenicek T, Szerda F, Demirović A, Mijić A, Kruslin B, Tomas D.

Pathol Int. 2007 Oct;57(10):694-7.

PMID:
17803659
10.

Interstitial laser hyperthermia model development for minimally invasive therapy of breast carcinoma.

Robinson DS, Parel JM, Denham DB, González-Cirre X, Manns F, Milne PJ, Schachner RD, Herron AJ, Comander J, Hauptmann G.

J Am Coll Surg. 1998 Mar;186(3):284-92.

PMID:
9510259
11.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
12.

Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.

Yang M, Moriya T, Oguma M, De La Cruz C, Endoh M, Ishida T, Hirakawa H, Orita Y, Ohuchi N, Sasano H.

Pathol Int. 2003 Jul;53(7):422-8.

PMID:
12828606
13.

Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).

Kluttig A, Trocchi P, Heinig A, Holzhausen HJ, Taege C, Hauptmann S, Boecker W, Decker T, Loening T, Schmidt-Pokrzywniak A, Thomssen C, Lantzsch T, Buchmann J, Stang A.

BMC Cancer. 2007 Jun 14;7:100.

14.

Breast cancer pseudometastasis in a sentinel lymph node with cytokeratin-positive debris.

Rao RS, Taylor J, Palmer J, Jennings WC.

Breast J. 2005 Mar-Apr;11(2):134-7.

PMID:
15730460
16.

Stereotactic uses beyond core biopsy: model development for minimally invasive treatment of breast cancer through interstitial laser hyperthermia.

Robinson DS, Parel JM, Denham DB, Manns F, Gonzalez X, Schachner R, Herron A, Burdette EC.

Am Surg. 1996 Feb;62(2):117-8.

PMID:
8554188
17.

Nuclear localization of cytokeratin 8 and the O-linked N-acetylglucosamine-containing epitope H in epithelial cells of infiltrating ductal breast carcinomas: a combination of immunogold and EDTA regressive staining methods.

Havaki S, Voloudakis-Baltatzis I, Goutas N, Arvanitis LD, Vassilaros SD, Arvanitis DL, Kittas C, Marinos E.

Ultrastruct Pathol. 2006 May-Jun;30(3):177-86.

PMID:
16825119
18.
19.

Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.

Prasad R, Boland GP, Cramer A, Anderson E, Knox WF, Bundred NJ.

Cancer. 2003 Dec 15;98(12):2539-46.

20.

Supplemental Content

Support Center